Cancer Drugs & Treatments Market 2023
(PRWEB) May 21, 2014
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023
GMR Data forecast that the global cancer drugs and treatments market will reach $143.7bn by 2023. GMR Dates latest report "The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023" explains just how this market will experience growth over the medium and long term. The report also highlights forecast for the next 5 and 10 years, so that you and your company can make specific long term plans. Don't let your competitors get the head-start on you, order this report today.
Have you seen the recent news on Cancer Drugs?
Merck’s new cancer drug kept more than 4 of 5 melanoma patients alive for a year
Bophirima Alliances will be needed For Cancer Drugs in the cost conscious future Forbes
EU approval for Buyers prostate cancer drug
The Anti-cancer treatment market is already worth $77.4bn (GMR Data) and continues to be one of the largest and fastest growing areas for new drug development can you afford not to be involved? Should you and your company be capturing a greater market share?
Essential facts examined in this report
1] Across 2013, 15 new molecular entities were approved by the FDA; out of which seven were for Oncology.
2] Currently targeted therapies dominate the oncology pipeline, followed by chemotherapy.
3] Immunotherapy drugs are gaining increasing amounts of attention due to fewer expected side effects.
To Download Full Report with TOC:
Only by ordering this in-depth exclusive report will you have full access to the unique findings. This information is not available anywhere else. Find full details of these approved drugs alongside key cancer drugs in their testing phases in this new GMR Data report.
Discover exactly what the industry leaders are doing today -
Within GMR Dates "The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023", we analyze the key cancer drugs and treatments in the market currently and how they will perform across the next decade.
Our study focuses on the individual revenues of the top 25 anti-cancer agents. With variable patents and the threat of generics, how will these key cancer drugs fare across the next decade? Only This Unique Report Will Tell You
Plus in-depth country analysis; discover which countries and regions will drive the oncology drugs market to 2023?
The US spent $322bn on healthcare in 2011; GMR Data estimate that the US spent $31.8bn in the oncology market in 2012, capturing 40.5% of the market. 2nd to the US was Japan; spending $8.9bn in 2012, capturing 11.2%. The European mainstays of the pharmaceutical sector; the UK, Germany, France, Spain & Italy equated to 25% of the global oncology market in 2012.
To Read More Reports With TOC:
But how will these countries markets develop? This report will tell you - today.
Exclusive industry sourced information, not available anywhere else
As well as primary and secondary research sources, GMR Data have interviewed leading cancer specialists within big pharmacy, R&D, wholesalers, distributors, marketers and key clinical organizations. From these interviews we have selected original, exclusive, transcribed interviews with leading specialists in their field this information is not available anywhere else.
This GMR Data report is the single tool to equip you with the latest trends in all regional markets and why all stakeholders demand development of Cancer Drugs. This report will arm you with all you and your company requires developing, price, launching and marketing a cancer drug.
Global and China Biodegradable Plastics Industry Report, 2013 - 2016
Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/an in 2012-2013. Among dozens of biodegradable plastic varieties developed so far, only plasters material (PSM), polylactic acid (PLA), poly (butylenes succinct) (PBS) have realized mass industrial production. In 2013, PSM, PLA and PBS accounted for 87% of the world’s total capacity.
In 2013, demand from Europe and North America, the two main biodegradable plastic markets around the world, for biodegradable plastics accounted for 54% and 28%, respectively. Germany-based BASF, U.S.-based Nature Works (Thailand’s PTT Chemical paid US$150 million for a 50% stake in Nature Works in December 2011), Italy’s Movement as well as the Netherlands-based Purace are the world’s major suppliers of biodegradable plastics, with capacity of 140 kit/a, 140 kit/a, 80 kit/a, 80 kit/a, respectively.
To Download Full Report with TOC:
China as one of the world’s important suppliers of biodegradable plastics accounts for about 20% of global production capacity. In 2009-2013, its biodegradable plastic capacity grew at a compound annual growth rate of over 21%. And, under the stimulus of favorable national policies as well as expanding range of applications, many domestic enterprises have embarked on new construction or expansion of biodegradable plastics.
As a leader in domestic plastics industry, Kanga Sic & Tech Co., Ltd. mainly produces modified plastics, specialty engineering plastics, completely biodegradable plastics, carbon fiber and composite materials, of which, the 30 kit/a PBS and polybutylene succinct adulate (PBSA) has been put into operation in Zhuhai in 2011, the Phase II 90 kit/a PBSA expansion project will be launched. Meanwhile, Kanga is also increasing intensity of downstream demand expansion. The company has signed biodegradable plastic mulch demonstrative application agreements with Xinjiang Production and Construction Corps, Huizhou, Shandong and other provinces and cities in early 2014.
Plant Growth Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Plant growth regulators, also known as plant hormones are chemicals occurring in low concentrations, which promote plant growth by increasing the supply or availability of primary nutrients to the plant. Various plant growth regulators such as cytokines, axons, and mepiquat chloride are used in certain agriculture and pharmaceutical applications.
The report on plant growth regulators provides a detailed analysis and forecast of the market on a global as well as regional level. On a global level, the market has been segmented on the basis of revenue (USD million) for a period ranging from 2013 to 2019. For an in-depth understanding of the market on the regional level, the demand has been forecast based on revenue (USD million). The report includes drivers and restraints and their impact on the growth of the market during the forecast period. Furthermore, the report covers opportunities available for the growth of the market during the forecast period on a global as well as regional level.
For a detailed understanding of the market, we have provided a thorough analysis of the value chain. Additionally, we have covered the Porter’s five forces model, which provides a detailed understanding of the intensity of competition in the market. Furthermore, the study includes a market attractiveness analysis, wherein the products are benchmarked based on market size, growth rate and general attractiveness.
To Download Full Report with TOC:
Plant Growth Regulators Market: Product Segment Analysis
Others (Mepiquate chloride, gibberellins, etc.)
Plant Growth Regulators Market: Regional Analysis
Rest of the World (Latin America, Africa and Middle East)
MarketResearchReports.biz [http://www.marketresearchreports.biz/ is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948